Attenuation of Benign Prostatic Hyperplasia by Optimized Tadalafil Loaded Pumpkin Seed Oil-Based Self Nanoemulsion: In Vitro and In Vivo Evaluation

The FDA has approved tadalafil (TDL) for the treatment of benign prostatic hyperplasia (BPH)-associated symptoms. Pumpkin seed oil (PSO) has shown promise for the relief of prostatitis-related lower urinary tract symptoms. The aim was to improve TDL delivery to the prostate and assess the combined e...

Descripción completa

Detalles Bibliográficos
Autores principales: Alhakamy, Nabil A., Fahmy, Usama A., Ahmed, Osama A. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6955804/
https://www.ncbi.nlm.nih.gov/pubmed/31805693
http://dx.doi.org/10.3390/pharmaceutics11120640

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6955804/
https://www.ncbi.nlm.nih.gov/pubmed/31805693
http://dx.doi.org/10.3390/pharmaceutics11120640

Ejemplares similares